Insmed Incorporated
INSM
$189.70
$4.022.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.03% | -25.37% | -8.93% | -6.81% | 26.64% |
| Total Depreciation and Amortization | 7.75% | 22.97% | 18.35% | 0.91% | 1.06% |
| Total Amortization of Deferred Charges | -11.56% | -4.78% | 2.50% | 9.71% | -10.45% |
| Total Other Non-Cash Items | 29.73% | 82.89% | 774.82% | -87.55% | -62.04% |
| Change in Net Operating Assets | 45.69% | 114.43% | -335.01% | 278.77% | -139.76% |
| Cash from Operations | -6.90% | 21.56% | -33.73% | -8.33% | -47.14% |
| Capital Expenditure | 30.60% | 65.40% | -48.70% | -83.57% | 45.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -428.47% | 155.65% | -34.68% | 113.86% | -- |
| Cash from Investing | -434.55% | 183.33% | -38.97% | 113.13% | -14,693.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 72.30% | -282.01% | -2.92% | -4.26% | -2.02% |
| Issuance of Common Stock | -96.03% | 2,796.93% | 116.38% | -96.55% | -49.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -96.11% | 2,858.16% | -81.80% | -59.89% | -49.17% |
| Foreign Exchange rate Adjustments | -197.11% | 12.29% | 159.47% | -181.84% | 367.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.77% | 680.48% | -262.20% | 111.92% | -220.62% |